drug

CDR132L

1 story · latest Aug 26, 2026

Status: Investigational
Trials: 4 registered trials in coverage

Relationships

Developed by Novo Nordisk A/S

Developed by Cardiol Therapeutics Inc.

Timeline

Cardior posts Phase 2 HF-REVERT results for CDR132L in post-MI heart failure

Aug 26Trial updateCardiol Therapeutics Inc.CDR132L

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.